Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06731439 · ClinicalTrials.gov registry record · NA
Does Starting Feeds on the First Day of Life Help Premature Infants Reach Full Volume Feeds Sooner?
A NA study of Premature Infant Disease and Extra Uterine Growth Restriction, sponsored by University of Tennessee.
- Recruiting
- Registry status
- NA
- Development phase
- 248
- Enrollment target
- 1
- Study location
NCT06731439: Recruiting NA study of Premature Infant Disease and Extra Uterine Growth Restriction, sponsored by University of Tennessee.
NCT06731439 is a NA study of Premature Infant Disease and Extra Uterine Growth Restriction that is actively recruiting participants, run by University of Tennessee. The registered enrollment target is 248 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06731439, a NA study of Premature Infant Disease and Extra Uterine Growth Restriction, is actively recruiting participants, sponsored by University of Tennessee.
- RECRUITING
- Registry status
- NA
- Development phase
- 248 participants
- Enrollment target
- 1
- Study location
Study Summary
Feeding advancements in ELBW infants have evolved over decades. The fear of causing mortality and morbidity, notably NEC, have made providers cautious when advancing feeds. ELBW infants initially remained NPO for several days before initiating trophic feeds. However, data then showed that there was no increase in mortality and morbidity if trophic feeds were initiated earlier. Then data showed that a short duration of trophic feeds did not increase mortality and morbidity when compared to a prolonged duration. More recent data showed that enteral feeding should be initiated early, preferably within 24 hours of birth, because it may promote feeding tolerance, shorten the time to reach total enteral feeding, and reduce the incidence of extrauterine growth restriction and late onset sepsis without increasing the risk of developing NEC. The management of enteral nutrition in ELBW infants is still very variable. For example, there is no consensus on the optimal time point after birth at which enteral nutrition can be started. This study evaluates the benefits of starting feeds by 6 hours of life Purpose: The primary aim of this study is to evaluate if in infants ≤ 1000g birth weight, is there a benefit initiating feeds by 6 hours of life (compared to current feeding practice data of 3 days of life) on decreasing the time to attain full feeds in the first 30 days of life. The secondary aim is to evaluate if antenatal feeding discussions would streamline feeding management post-delivery.
Primary Outcome
The primary outcome is the age in days in the first 30 days of life when the infant reaches full feeds.
Conditions Studied
Interventions
- OTHER Starting feeds within 6 hours of life
- OTHER Standard feeding protocol
Study Locations (1)
Tennessee
- Regional One Health - Memphis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 248 participants |
| Start Date | 2024-06-01 |
| Est. Completion | 2027-06-30 |
| Phase | NA |
What NCT06731439 shows while recruiting
NCT06731439 is an interventional study that assigns participants to a tested intervention. The registered 248 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower).
The record links to 3 conditions, with Premature Infant Disease appearing as the primary indexed condition, and to 2 interventions - of which Starting feeds within 6 hours of life is the first listed.
NCT06731439 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT06731439 about?
NCT06731439 is a clinical study titled "Does Starting Feeds on the First Day of Life Help Premature Infants Reach Full Volume Feeds Sooner?". Feeding advancements in ELBW infants have evolved over decades. The fear of causing mortality and morbidity, notably NEC, have made providers cautious when advancing feeds. ELBW infants initially remained NPO for several days before initiating trophic feeds. However, data then showed that there was ...
What is the current status of trial NCT06731439?
This trial is currently recruiting. It is a NA study. The enrollment target is 248 participants. The study started on 2024-06-01. Estimated completion is 2027-06-30.
What conditions does trial NCT06731439 study?
This clinical trial studies the following conditions: Premature Infant Disease, Extra Uterine Growth Restriction, VLBW - Very Low Birth Weight Infant.
What interventions are being tested in trial NCT06731439?
The interventions under investigation include: Starting feeds within 6 hours of life (OTHER), Standard feeding protocol (OTHER).
Who is sponsoring clinical trial NCT06731439?
This trial is sponsored by University of Tennessee, which has 96 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06731439 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Premature Infant Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06731439's enrollment target sits among peer trials
248 434th of 2000 higher than 1,565 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04577911 · 248 participants
How is Social Connection Represented in the Brain?
- NCT04777994 · 248 participants · Phase 1
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
- NCT04792489 · 248 participants · Phase 2
DALY II USA/ MB-CART2019.1 for DLBCL
- NCT04830137 · 248 participants · Phase 1
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI